Earnings Call · Q1 FY2023·2023-05-15

Q1 23EPS +46.89%·Rev n/aQ4 22EPS +64.82%·Rev n/aQ3 22EPS -71.43%·Rev n/aQ2 22EPS +36.84%·Rev n/a⚠ consensus missing

Jaguar Health, Inc. JAGX

Lisa Conte — Founder, President and CEO

Sandra Swain — Breast Cancer Medical Oncologist and Professor of Medicine at Georgetown

−22.6%1d on move date−22.9% vs SPY3d−30.6%5d−32.2%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more JAGX calls or request research access.

More JAGX calls Browse calls Request research access